Those price sensitive announcements were never going to give any traction to the SP while the removal from the asx200 was a possibility (I thought high probability).
Price action wise we can probably forget they ever happened, although they definitely add value in the long term.
Hopefully this recent buying is in (ahem) ‘anticipation of’ a chunky announcement. It would be nice if they partnered one of their non lead candidates or something of that ilk.
I’ve sold my loose trading stock too cheap; expecting a pullback from the mid $2.40s which didn’t happen yet although I’m still holding heaps as a core which I won’t trade.
I’ll be happy if it pulls back to $2.30ish so I can rebuy my trading parcel although I’d prefer that it keeps going and fwiw I think it will.
Maybe another entity puts a squeeze on?
Interesting times but the short thesis is nowhere near as solid as it was a few months ago with the sector on the verge of a breakout, the rebalance thingo done and dusted and the orange twat having gone quiet on pharmaceuticals.
Only the need for capital in 6-8 months or so is a handbrake for now which could be gone quickly if someone big wants a chunk.
CU6 Price at posting:
$2.52 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)